Barriers in the implementation of guidelines for acute coronary syndromes. Focus on antiplatelet therapy

The use of modern guidelines-recommended treatment (DES or novel antiplatelet agents) is surprisingly poor and is not limited by economic restrictions but rather by lack of guidelines knowledge or lack of physicians' activity to quickly implement the new guidelines.